Lv53
910 积分 2025-10-09 加入
Global trends in early-onset liver cancer incidence and projections to 2050 based on the global burden of disease study 2021
27天前
已完结
Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data
1个月前
已完结
Can we consider stopping hepatocellular carcinoma surveillance in low-risk patients with hepatitis B?
1个月前
已完结
Prospects for leveraging knowledge on ISG and NF-kB effector functions into anti-HBV therapies
2个月前
已关闭
Epigenetic Modifications in HBV‐Related Hepatocellular Carcinoma
2个月前
已完结
The APOBEC3 family: a narrative review of an alternative therapeutic agent for hepatitis B virus-induced hepatocellular carcinoma
2个月前
已完结
Interferons in health and disease
2个月前
已完结
Type I interferons in health and disease: molecular aspects and clinical implications
2个月前
已完结
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta
2个月前
已完结
Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection
2个月前
已完结
皖公网安备34019202002308
